Mutations of phosphorylation sites Ser10 and Thr187 of p27Kip1 abolish cytoplasmic redistribution but do not abrogate G0/1 phase arrest in the HepG2 cell line

Biochemical and Biophysical Research Communications

Volumn 347, Issue 3, 2006, Pages 601-607

  Guan, Xiaoxiang ^a   Chen, Longbang ^a   Wang, Jinghua ^a   Geng, Huaicheng ^a   Chu, Xiaoyuan ^a   Zhang, Qun ^a   Du, Lili ^a   De, Wei ^b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Mutant; p27Kip1; Phosphorylation; Subcellular localization

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; LEPTOMYCIN B; LIPOFECTAMINE; SERINE; THREONINE;

ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN HEPG2; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTOPLASM; FATTY ACIDS, UNSATURATED; G0 PHASE; G1 PHASE; HUMANS; MUTATION; PHOSPHOSERINE; PHOSPHOTHREONINE; RECOMBINANT PROTEINS; STAUROSPORINE;

EID: 33746215067     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.06.114     Document Type: Article

References (31)

1. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13 (1999) 1501-1512
2. Nakayama K., and Nakayama K. Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development. Bioessays 20 (1998) 1020-1029
3. Polyak K., Lee M.H., Erdjument-Bromage H., Koff A., Roberts J.M., Tempst P., and Massague J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78 (1994) 59-66
4. Min Y.H., Cheong J.W., Kim J.Y., Eom J.I., Lee S.T., Hahn J.S., Ko Y.W., and Lee M.H. Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia. Cancer Res. 64 (2004) 5225-5231
5. Ishida N., Kitagawa M., Hatakeyama S., and Nakayama K. Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability. J. Biol. Chem. 275 (2000) 25146-25154
6. Ishida N., Hara T., Kamura T., Yoshida M., Nakayama K., and Nakayama K.I. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 277 (2002) 14355-14358
7. Rodier G., Montagnoli A., Marcotullio L.D., Coulombe P., Draetta G.F., Pagano M., and Meloche S. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J. 20 (2001) 6672-6682
8. Ekholm S.V., and Reed S.I. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr. Opin. Cell Biol. 12 (2000) 676-684
9. Slingerland J., and Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell Physiol. 183 (2000) 10-17
10. Montagnoli A., Fiore F., Eytan E., Carrano A.C., Draetta G.F., Hershko A., and Pagano M. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 13 (1999) 1181-1189
11. Vlach J., Hennecke S., and Amati B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1. EMBO J 16 (1997) 5334-5344
12. Sgambato A., Cittadini A., Faraglia B., and Weinstein I.B. Multiple functions of p27(Kip1) and its alterations in tumor cells: a review. J. Cell Physiol. 183 (2000) 18-27
13. Blain S.W., Scher H.I., Cordon-Cardo C., and Koff A. p27 as a target for cancer therapeutics. Cancer cell. 3 (2003) 111-115
14. Katner A.L., Hoang Q.B., Gootam P., Jaruga E., Ma Q., Gnarra J., and Rayford W. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1). Prostate 53 (2002) 77-87
15. Yang H.Y., Zhou B.P., Hung M.C., and Lee M.H. Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27. J. Biol. Chem. 275 (2000) 24735-24739
16. Chiarle R., Budel L.M., and Skolink J. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood 95 (2000) 619-626
17. Catzavelos C., Bhattacharya N., Ung Y.C., Wilson J.A., Roncari L., Sandhu C., Shaw P., Yeger H., Morava-Protzner I., Kapusta L., Franssen E., Pritchard K.I., and Slingerland J.M. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat. Med. 3 (1997) 227-230
18. Yang G., Ayala G., Marzo A.D., Tian W., Frolov A., Wheeler T.M., Thompson T.C., and Harper J.W. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin. Cancer Res. 8 (2002) 3419-3426
19. Loda M., Cukor B., Tam S.W., Lavin P., Fiorentino M., Draetta G.F., Jessup J.M., and Pagano M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 3 (1997) 231-234
20. Baldassarre G., Belletti B., Bruni P., Boccia A., Trapasso F., Pentimalli F., Barone M.V., Chiappetta G., Vento M.T., Spiezia S., Fusco A., and Viglietto G. Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells. J. Clin. Invest. 104 (1999) 865-874
21. Jiang Y., Zhao R.C., and Verfaillie C.M. Abnormal integrin-mediated regulation of chronic myelogenous leukemia CD34+ cell proliferation: BCR/ABL up-regulates the cyclin-dependent kinase inhibitor, p27Kip, which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity. Proc. Natl. Acad. Sci. USA 97 (2000) 10538-10543
22. Soucek T., Yeung R.S., and Hengstschlager M. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc. Natl. Acad. Sci. USA 95 (1998) 15653-15658
23. Orend G., Hunter T., and Ruoslahti E. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Oncogene 16 (1998) 2575-2583
24. Singh S.P., Lipman J., Goldman H., Ellis F.H.J., Aizenman L., Cangi M.G., Signoretti S., Chiaur D.S., Pagano M., and Loda M. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res. 58 (1998) 1730-1735
25. Viglietto G., Motti M.L., Bruni P., Melillo R.M., D'Alessio A., Califano D., Vinci F., Chiappetta G., Tsichlis P., Bellacosa A., Fusco A., and Santoro M. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat. Med. 8 (2002) 1136-1344
26. Liang J., Zubovitz J., Petrocelli T., Kotchetkov R., Connor M.K., Han K., Lee J.H., Ciarallo S., Catzavelos C., Beniston R., Franssen E., and Slingerland J.M. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 8 (2002) 1153-1160
27. Shin I., Yakes F.M., Rojo F., Shin N.Y., Bakin A.V., Baselga J., and Arteaga C.L. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat. Med. 8 (2002) 1145-1152
28. Viglietto G., Motti M.L., and Fusco A. Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization. Cell Cycle 1 (2002) 394-400
29. Rodier G., Montagnoli A., Marcotullio L.D., Coulombe P., Draetta G.F., Pagano M., and Meloche S. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J. 20 (2001) 6672-6682
30. Kawamata N., Morosetti R., Miller C.W., Park D., Spirin K.S., Nakamaki T., Takeuchi S., Hatta Y., Simpson J., and Wilcyznski S. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res. 55 (1995) 2266-2269
31. Blain S.W., and Massague J. Breast cancer banishes p27kip1 from nucleus. Nat. Med. 8 (2002) 1076-1078